Alliance Pharma (APH) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Feb 2004 12:01 PM
RNS
Directorate Change
12 Feb 2004 04:33 PM
RNS
Loan Stock Interest Payment
10 Feb 2004 07:00 AM
RNS
Acquisition
06 Feb 2004 09:52 AM
RNS
Directorate Change
22 Dec 2003 12:35 PM
RNS
Result of EGM
22 Dec 2003 07:00 AM
RNS
Result of Open Offer
01 Dec 2003 12:53 PM
RNS
Doc re Prospectus
28 Nov 2003 05:06 PM
RNS
Acquisition
30 Sep 2003 10:25 AM
RNS
Interim Results
20 Jun 2003 05:03 PM
RNS
Result of EGM
23 May 2003 03:24 PM
RNS
Final Results
31 Jan 2003 02:30 PM
RNS
Holding(s) in Company
23 Dec 2002 01:15 PM
RNS
Holding(s) in Company
24 Oct 2002 09:37 AM
RNS
Holding(s) in Company
30 Sep 2002 10:12 AM
RNS
Interim Results
15 Aug 2002 02:16 PM
RNS
Director Shareholding
12 Jul 2002 05:10 PM
RNS
Director Shareholding
28 Jun 2002 01:08 PM
RNS
Availability of Final Results
28 Jun 2002 12:57 PM
RNS
Final Results
28 Jun 2002 11:04 AM
RNS
Interest in Shares
21 Jun 2002 05:35 PM
RNS
Director Shareholding
01 May 2002 10:41 AM
RNS
Director Shareholding
25 Apr 2002 04:50 PM
RNS
Director Shareholding
04 Dec 2001 04:10 PM
RNS
Holding in Company

Alliance Pharma markets prescription medicines and consumer healthcare products, including Nizoral™ anti-dandruff shampoo and KELO-COTE™ silicone scar treatment.

It operated in 100 countries, including the UK, Ireland, Mainland Europe, the British Virgin Islands, France, the US, and Germany.

Alliance share price launched at 51p in 2001.

UK 100

Latest directors dealings